Yazar "I-1735-2018" için listeleme
-
Biomolecular Markers for Improving Management of Follicular and Medullary Thyroid Cancer
Mousa, Umut; Anil, Cuneyd; Isildak, Serife Mehlika; Gursoy, Alptekin; Carpi, Angelo (2014)Thyroid cancer usually presents as a thyroid nodule. According to different reports, more than 95% of thyroid nodules are benign. The gold standard for preoperative diagnosis of thyroid cancer is fine-needle aspiration ... -
Do Statins Affect Thyroid Volume and Nodule Size in Patients with Hyperlipidemia in a Region with Mild-to-Moderate Iodine Deficiency? A Prospective Study
Bozkus, Yusuf; Demir, Canan; Anil, Cuneyd; Mousa, Umut; Kut, Altug; Nar, Asli; Tutuncu, Neslihan B. (2018)Objective: The objective of this study was to assess the anti-proliferative pleiotropic effects of statins on thyroid function, volume, and nodularity. Subjects and Methods: One hundred and six hyperlipidemic patients were ... -
Knowledge, Attitudes and Behaviors of Physicians Towards Thyroid Disorders and Iodine Requirements in Pregnancy
Kut, A.; Kalli, H.; Anil, C.; Mousa, U.; Gursoy, A. (2015)Purpose Thyroid disorders including iodine deficiency during pregnancy are important health problems worldwide. However, considering real life, assessment of knowledge, attitudes, and practice of physicians is lacking. We ... -
Short-Term Effect of Hypergastrinemia Following Esomeprazole Treatment On Well-Controlled Type 2 Diabetes Mellitus: A Prospective Study
Bozkus, Yusuf; Mousa, Umut; Iyidir, Ozlem T.; Kirnap, Nazli; Demir, Canan C.; Nar, Asli; Tutuncu, Neslihan B. (2020)Objective: Proton pump inhibitor (PPI) drugs reduce gastric acid secretion and lead to an increase in serum gastrin levels. Many preclinical and some clinical researches have established some positive effects of gastrin ... -
Stimulated Thyroglobulin Values Above 5.6 Ng/Ml Before Radioactive Iodine Ablation Treatment Following Levothyroxine Withdrawal Is Associated with A 2.38-Fold Risk of Relapse in Tg-Ab Negative Subjects with Differentiated Thyroid Cancer
Mousa, U.; Yikilmaz, A. S.; Nar, A. (2017)Serum thyroglobulin (Tg) is the key parameter used in the follow-up of subjects with differentiated thyroid cancer (DTC). Current guidelines advise its measurement to take place when Thyrotropin (TSH) levels are > 30 A mu ...